Amelioration of inflammation in IUGR males treated with ICA was confirmed by a decrease in the levels of inflammatory factors, like IL‐6 and TNF‐α, in comparison to those in IUGR males (Figure 8f). This evidence concerns the gene IL6 and fetal growth restriction.